Filter Results:
(622)
Show Results For
- All HBS Web
(622)
- People (2)
- News (57)
- Research (448)
- Events (2)
- Multimedia (9)
- Faculty Publications (392)
Show Results For
- All HBS Web
(622)
- People (2)
- News (57)
- Research (448)
- Events (2)
- Multimedia (9)
- Faculty Publications (392)
- January 2016 (Revised February 2016)
- Course Overview Note
The Sustainable Core: Operations Management
By: Michael W. Toffel and L. Beril Toktay
This note is designed to help faculty embed environmental sustainability content into their core Operations Management course at the MBA or undergraduate level. It can also be used to identify cases with environmental content that can be used in operations electives... View Details
Keywords: Environmental Management; Operations Management; Sustainable Operations; Environmental Regulation; Operations; Supply Chain; Supply Chain Management; Agriculture and Agribusiness Industry; Biotechnology Industry; Food and Beverage Industry; Construction Industry; Forest Products Industry; Retail Industry
Toffel, Michael W., and L. Beril Toktay. "The Sustainable Core: Operations Management." Harvard Business School Course Overview Note 616-022, January 2016. (Revised February 2016.)
- September 2009 (Revised December 2009)
- Supplement
Genzyme Center (B)
By: Michael W. Toffel and Aldo Sesia
Genzyme Corporation is in the midst of planning its new corporate headquarters, which incorporates many innovative green building features. After learning that the building as planned would likely earn a LEED Silver rating, an intermediate score in the LEED green... View Details
Keywords: Environmental Sustainability; Corporate Social Responsibility and Impact; Standards; Cost vs Benefits; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry
Toffel, Michael W., and Aldo Sesia. "Genzyme Center (B)." Harvard Business School Supplement 610-009, September 2009. (Revised December 2009.)
- 01 Sep 2011
- News
Green Day
good ROI.” Diniz began to brainstorm with Paulo Puterman, a friend studying to get his PhD in biotechnology at the University of São Paulo who also happened to be focused on the highly efficient elephant grass/electricity equation. “After... View Details
- 03 Dec 2001
- Research & Ideas
Healthcare Conference Looks At Ailing Industry
Mixing Risk And Reward The basic model that the biotechnology industry has followed for over twenty years is also changing, and for the better, according to panelists at a session titled "Will Equal Biotechnology-Pharma Partnerships... View Details
- 15 Feb 2022
- Blog Post
Health is Wealth | The Path to Creating a Venture
her sleep patterns – to try to improve her performance. It was during this time that she connected with Wallerstofer, who had a PhD in biotechnology and had spent the previous decade building consumer facing nutrition products based on... View Details
- Web
Dean Srikant Datar’s 2023 Commencement Remarks | About
join the biotechnology firm Vertex, where she led teams to make innovative medicines that treat chronic diseases like cystic fibrosis. Amid a busy career, Depelsha McGruder acted courageously to launch Moms of Black Boys United to... View Details
- 1997
- Chapter
Patent Scope and Emerging Industries: Biotechnology, Software, and Beyond
By: Josh Lerner and Robert P. Merges
Keywords: Patents; Applications and Software; Genetics; Biotechnology Industry; Biotechnology Industry
Lerner, Josh, and Robert P. Merges. "Patent Scope and Emerging Industries: Biotechnology, Software, and Beyond." In Competing in the Age of Digital Convergence, edited by D. B. Yoffie, 301–324. Boston: Harvard Business School Press, 1997.
- 26 Sep 2006
- First Look
First Look: September 26, 2006
Danner was about to make his first presentation to the board of directors of Codon Devices, a one-year-old biotechnology start-up based in Cambridge, Massachusetts. After a month as the company's CEO, Danner was prepared to lay out his... View Details
Keywords: Sean Silverthorne
- 06 Jun 2017
- First Look
First Look at New Research and Ideas: June 6, 2017
Pharmacyclics is a biotechnology company that had received FDA approval in late 2013 for its flagship asset Imbrivica (ibrutinib), a biologic treatment for chronic lymphocytic leukemia and two other even rarer blood malignancies. Entering... View Details
Keywords: Sean Silverthorne
- Web
Winners & Success Stories | New Venture Competition
Pharmaceuticals Alec Machiels, MBA 2001 Potentia is a clinical-stage biotechnology company with a world-class scientific team and scientific advisory board. The company’s mission is to bring the first treatment targeting the root cause of... View Details
- January 2007 (Revised January 2007)
- Background Note
Note on the U.S. Food and Drug Administration
By: Robert F. Higgins, Richard G. Hamermesh and Virginia Fuller
Describes the U.S. FDA with particular emphasis on its role in the development of new drugs, biologic products, and medical devices today. Provides context for the drug approval process by describing the FDA's history and organizational structure. View Details
Keywords: Health; Governance Compliance; Policy; Product Development; Government and Politics; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; United States
Higgins, Robert F., Richard G. Hamermesh, and Virginia Fuller. "Note on the U.S. Food and Drug Administration." Harvard Business School Background Note 807-050, January 2007. (Revised January 2007.)
- May 20, 2016
- Comment
World Health Organization Lacks Leadership to Combat Pandemics
By: John A. Quelch
When it comes to emergency preparedness for pandemics, the World Health Organization is falling short. It has not provided prompt and clear leadership to the world in combating either the Ebola or Zika viruses. Its leadership has been low energy, its representatives... View Details
Keywords: Global Health; World Health Organization; World Bank; Pandemics; Emergency Preparedness; Experience and Expertise; Decisions; Forecasting and Prediction; Communication Strategy; Nonverbal Communication; Framework; Governance; Government and Politics; Health; Management; Practice; Problems and Challenges; Projects; Risk and Uncertainty; Human Needs; Civil Society or Community; Social Issues; Welfare or Wellbeing; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Africa; Asia; Europe; Latin America; North and Central America; South America; West Indies
Quelch, John A. "World Health Organization Lacks Leadership to Combat Pandemics." Harvard Business School Working Knowledge (May 20, 2016).
- 01 Feb 2011
- First Look
First Look: Feb. 1
greenhouse gas emissions. The case describes challenges facing this small agricultural biotechnology company, notably uneven enforcement of intellectual property in emerging market countries and uncertainty regarding the provision and... View Details
- 15 Oct 2008
- First Look
First Look: October 15, 2008
Science. Vol. 1, edited by Susan S. Silbey, 367-398. England: Ashgate Publishing, Limited, 2008 Abstract During the past 15 years, new biotechnology companies have promoted DNA typing as a sophisticated criminal and paternity... View Details
Keywords: Martha Lagace
- 03 Sep 2013
- First Look
First Look: September 3
results. Purchase this case: http://hbr.org/search/713537-PDF-ENG Harvard Business School Case 814-014 Sample6: Innovating to Make Food Safer Tim Curran, CEO of Sample6, a start-up biotechnology company developing a novel food safety... View Details
Keywords: Sean Silverthorne
- 26 Jun 2000
- Research & Ideas
Presentation Round-Up
recently joined with the private company Celera Genomics to announce the cracking of the human genetic code.) Increasing interest in such research has led to complex legal tangles. Patent attorney Brenda Herschbach Jarrell of Choate, Hall & Stewart, who specializes... View Details
- 01 Dec 2004
- News
The Future of Stem Cells
sickle cell anemia.) A board member and former chair of the Massachusetts Biotechnology Council, Fisher says states are stepping up to fund stem-cell work, partly in response to their constituents who want the jobs and businesses — as... View Details
Keywords: Garry Emmons
- 18 Sep 2019
- Working Paper Summaries
Female Inventors and Inventions
- Research Summary
Overview
I am interested in the individual experience of learning in organizational settings, particularly how employees learn to learn from the challenging work they do.
I am currently researching the role of reflection for raising awareness of learning opportunities that... View Details
- Article
Internal Deadlines, Drug Approvals, and Safety Problems
By: Lauren Cohen, Umit Gurun and Danielle Li
Absent explicit quotas, incentives, reporting, or fiscal year-end motives, drug approvals around the world surge in December, at month-ends, and before respective major national holidays. Drugs approved before these informal deadlines are associated with significantly... View Details
Keywords: Health; Economics; Government and Politics; Innovation and Invention; Research; Science; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry
Cohen, Lauren, Umit Gurun, and Danielle Li. "Internal Deadlines, Drug Approvals, and Safety Problems." American Economic Review: Insights 3, no. 1 (March 2021): 67–82.